Krishna Institute of Medical Sciences Ltd (KIMS) Q1FY26 Concall Summary - Jun-2025 Qtr
Performance Overview
- Krishna Institute of Medical Sciences Ltd (KIMS) reported a total revenue of INR 879 crores, representing a year-on-year growth of 26.8% and a quarter-on-quarter growth of 9.6%.
- EBITDA reached INR 200 crores, showing a year-on-year increase of 8.5% but a quarter-on-quarter decline of 1.4%.
- EBITDA margin stood at 22.7%, compared to 26.6% in Q1 FY25 and 25.3% in Q4 FY25.
- Profit after tax (PAT) was INR 85 crores, lower than INR 95 crores in Q1 FY25 and INR 106 crores in Q4 FY25.
- The company launched new units in Thane, Bangalore (Mahadevpur and Electronic City), Kannur, Kollam, Seethammadhara (Visakhapatnam), and Srikakulam.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.